z-logo
open-access-imgOpen Access
The application of radionuclide infarct scintigraphy to diagnose perioperative myocardial infarction following revascularization.
Author(s) -
S C Klausner,
Elias H. Botvinick,
D M Shames,
Daniel J. Ullyot,
Noel H. Fishman,
Benson B. Roe,
P A Ebert,
Kanu Chatterjee,
William W. Parmley
Publication year - 1977
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.56.2.173
Subject(s) - medicine , myocardial infarction , scintigraphy , perioperative , revascularization , infarction , technetium , cardiology , radionuclide imaging , nuclear medicine , radiology , technetium 99m
To evaluate the application of radionuclide infarct scintigraphy to diagnose myocardial infarction after revascularization, we obtained postoperative technetium 99m pyrophosphate myocardial scintigrams, serial electrocardiograms and CPK-MB isoenzymes in ten control and 51 revascularized patients. All control patients had negative electrocardiograms and scintigrams, but eight had positive isoenzymes. Eight revascularized patients had positive electrocardiograms, images and enzymes and two had positive scintigrams and enzymes with negative electrocardiograms. Thirty-four patients with negative electorcardiograms and scintigrams had positive isoenzymes; in only seven patients were all tests negative. Our data suggest radionuclide infarct scintigraphy is a useful adjunct to the electrocardiogram in diagnosing perioperative infarction. The frequent presence of CPK-MB in postoperative patients without other evidence of infarction suggests that further studies are required to identify all factors responsible for its release.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom